Community Oncologist Education and Support Systems ‐
Renal Cell Carcinoma and Hematologic Malignancies
Request for Proposals
National Comprehensive Cancer Network and
Pfizer Independent Grants for Learning & Change
Pfizer and National Comprehensive Cancer Network (NCCN) are collaborating
to offer a new grant opportunity focused on improving care for patients with
rare types of cancer such as renal cell carcinoma (RCC) and certain hematologic
malignancies, where treatment options are complex and rapidly advancing.
The mission of Pfizer Independent Grants for Learning & Change (IGL&C) is
to accelerate the adoption of evidence‐based innovations that align the mutual
interests of patients, healthcare professionals, and Pfizer, through support
of independent professional education activities. The term “independent”
means the initiatives funded by Pfizer are the full responsibility of the
recipient organization. Pfizer has no influence over any aspect of the initiatives,
and only asks for reports about the results and impact of the initiatives,
which it may share publicly.
NCCN, a not‐for‐profit alliance of twenty‐three (23) of the world’s leading
cancer centers, is dedicated to improving the quality and effectiveness of
care provided to patients with cancer. Through the leadership and expertise
of clinical professionals at NCCN Member Institutions, NCCN develops
resources that present valuable information to the numerous stakeholders
in the health care delivery system. NCCN has access, through its member
institutions, to the world’s leading thought leaders in all areas and aspects
of oncology who are integral to the execution of this program.
This Request for Proposals (RFP) is being issued by both organizations. NCCN is
the lead organization for review and evaluation of applications. A review
committee, led by NCCN, will make decisions on which proposals will receive
funding. Grant funding will be provided by Pfizer. Collectively, up to $2 million
is available for the program.
Once announced through this distribution list, the RFP will also be
posted on our website at www.pfizer.com/
refer to the full text of the RFP for various key dates and submission
Please send an email to IGLC@pfizer.com to unsubscribe from this distribution.